PDCD1 and psoriasis: In summary, our data demonstrate increased BTLA expression in CD8 effector T cells and reduced PD-1 expression in all CD3-expressing subpopulations of patients with mild-to-moderate psoriasis, suggesting possible variation in T cell function if these co-inhibitory receptors are engaged.